Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer
1 other identifier
observational
3,000
0 countries
N/A
Brief Summary
The purpose of this study is to investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid cancer. Screen for the risk factors that affect the incidence of thyroid cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 26, 2016
CompletedFirst Posted
Study publicly available on registry
December 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedDecember 30, 2016
December 1, 2016
10 months
December 26, 2016
December 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
lipids
before the thyroid surgery
Secondary Outcomes (1)
glucose
before the thyroid surgery
Other Outcomes (4)
blood pressure
before the thyroid surgery
Uric Acid
before the thyroid surgery
sialic acid
before the thyroid surgery
- +1 more other outcomes
Study Arms (2)
The thyroid cancer group
The postoperative pathology of thyroid is malignant
The thyroid nodule group
The postoperative pathology of thyroid is benign
Eligibility Criteria
patients undergone thyroid surgery
You may qualify if:
- patients undergone thyroid surgery
- signed the informed consent
You may not qualify if:
- patients with no surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lin Liaolead
Related Publications (3)
Yao J, Zhao J, Liu J, Jiang S, Guo S, Xu L, Zhang X, Sheng Q, Wang K, Liao L, Dong J. The relationships between thyroid functions of short-term rapid hypothyroidism and blood lipid levels in post-thyroidectomy patients of differentiated thyroid cancer. Front Endocrinol (Lausanne). 2023 Apr 27;14:1114344. doi: 10.3389/fendo.2023.1114344. eCollection 2023.
PMID: 37181036DERIVEDZhao J, Tian Y, Jia Z, Yao J, Liao L, Dong J. Abnormal Glucose Metabolism Parameters and the Aggressiveness of Differentiated Thyroid Carcinoma: A Hospital-Based Cross-Section Study in China. Front Endocrinol (Lausanne). 2022 Mar 1;13:806349. doi: 10.3389/fendo.2022.806349. eCollection 2022.
PMID: 35299970DERIVEDZhao J, Tian Y, Yao J, Gu H, Zhang R, Wang H, Liao L, Dong J. Hypercholesterolemia Is an Associated Factor for Risk of Differentiated Thyroid Cancer in Chinese Population. Front Oncol. 2021 Jan 28;10:508126. doi: 10.3389/fonc.2020.508126. eCollection 2020.
PMID: 33585179DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Lin Liao, MD
Qianfoshan Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- chief of endocrinology department at Qianfoshan Hospital
Study Record Dates
First Submitted
December 26, 2016
First Posted
December 30, 2016
Study Start
December 1, 2016
Primary Completion
October 1, 2017
Study Completion
November 1, 2017
Last Updated
December 30, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will share